Erratum: In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|134|8|E4-E4

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.134, Iss.8, 2014-04, pp. : E4-E4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erratum: Inhibition of nuclear factor κb activity by genistein is mediated via Notch‐1 signaling pathway in pancreatic cancer cells

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : E3-E3

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synergistic Action of Genistein and Cisplatin on Growth Inhibition and Cytotoxicity of Human Medulloblastoma Cells

By  

Pediatric Neurosurgery, Vol. 33, Iss. 3, 2000-11 ,pp. : 123-131

Karger

Access to resources Recommend Favorite

Chemoprevention of Pancreatic Cancer: A Review of the Molecular Pathways Involved, and Evidence for the Potential for Chemoprevention

By  

Pancreatology, Vol. 6, Iss. 5, 2006-10 ,pp. : 429-439

Karger

Access to resources Recommend Favorite

Molecular Targeting in Pancreatic Cancer

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 1, 2007-01 ,pp. : 69-75

Bentham Science Publishers

Access to resources Recommend Favorite

PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo

By                  

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 995-1002

Spandidos Publications

Access to resources Recommend Favorite